YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart Failure

Not Applicable

Completed

Conditions: Congestive Heart Failure

Interventions: Device: BodyPort
Other: Conversa
Other: Noom

First Posted Date: 2020-05-19

Last Posted Date: 2023-05-18

Lead Sponsor: Yale University

Target Recruit Count: 182

Registration Number: NCT04394754

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)

Not Applicable

Completed

Conditions: High Risk Atherosclerotic Cardiovascular Disease

Interventions: Other: Electronic Alert

First Posted Date: 2020-05-19

Last Posted Date: 2022-07-26

Lead Sponsor: Yale University

Target Recruit Count: 2500

Registration Number: NCT04394715

Locations: 🇺🇸
Bridgeport Hospotal, Bridgeport, Connecticut, United States
🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
🇺🇸
St. Raphael's Hospital, New Haven, Connecticut, United States

and more 1 locations

TAP Block Using Liposomal Bupivacaine for Post-cesarean Delivery Analgesia- Walking Towards Recovery

Phase 4

Recruiting

Conditions: Opioid Use
Pain, Acute

Interventions: Drug: Dexamethasone and methylprednisolone (CG)
Drug: Liposomal bupivacaine (LB)
Drug: Control group (Bupivacaine)- (BPG)

First Posted Date: 2020-05-19

Last Posted Date: 2024-02-05

Lead Sponsor: Yale University

Target Recruit Count: 300

Registration Number: NCT04393207

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Tele-health Study of Stimulant-induced Improvement in Neurocognitive Functioning.

Phase 1

Terminated

Conditions: ADHD

Interventions: Other: Placebo
Drug: Calcitriol

First Posted Date: 2020-05-13

Last Posted Date: 2024-02-07

Lead Sponsor: Yale University

Target Recruit Count: 3

Registration Number: NCT04386811

Locations: 🇺🇸
CMHC, New Haven, Connecticut, United States

Preliminary Effectiveness of Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality

Not Applicable

Completed

Conditions: Alcohol Use Disorder

Interventions: Device: Soberlink

First Posted Date: 2020-05-08

Last Posted Date: 2023-05-26

Lead Sponsor: Yale University

Target Recruit Count: 96

Registration Number: NCT04380116

Locations: 🇺🇸
Aware Recovery Care, North Haven, Connecticut, United States

Thymectomy With and Without Povidone-iodine Pleural Lavage in Stage IVA Thymic Malignancies

Phase 1

Withdrawn

Conditions: Stage IVA Thymoma

Interventions: Drug: Intraoperative providone-iodine lavage

First Posted Date: 2020-05-01

Last Posted Date: 2022-07-25

Lead Sponsor: Yale University

Registration Number: NCT04371458

Toward a Computationally-Informed, Personalized Treatment for Hallucinations

Early Phase 1

Recruiting

Conditions: Hallucinations, Auditory
Psychosis

Interventions: Drug: Rivastigmine Transdermal System
Drug: Scopolamine
Drug: Placebo Patch

First Posted Date: 2020-04-29

Last Posted Date: 2024-07-25

Lead Sponsor: Yale University

Target Recruit Count: 35

Registration Number: NCT04366518

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)

Not Applicable

Not yet recruiting

Conditions: Polycystic Ovarian Syndrome in Adolescent Females
Vitamin D Deficiency

Interventions: Drug: Vitamin D 4000IU daily
Drug: Placebo

First Posted Date: 2020-04-21

Last Posted Date: 2024-11-07

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT04355572

Camostat Mesylate in COVID-19 Outpatients

Phase 2

Completed

Conditions: COVID-19

Interventions: Drug: Camostat Mesilate
Other: Placebo

First Posted Date: 2020-04-20

Last Posted Date: 2022-03-24

Lead Sponsor: Yale University

Target Recruit Count: 70

Registration Number: NCT04353284

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

An Augmented Reality Videogame for Alcohol Use Prevention and Harm Reduction in Teens

Not Applicable

Not yet recruiting

Conditions: Alcohol Prevention
Harm Reduction

First Posted Date: 2020-04-17

Last Posted Date: 2024-12-11

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT04351958

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy